LP-0184

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLP-0184
Drug Alias NameJAK1 inhibitors (LEO Pharma)LP-0184
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK1
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLeo Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesLeo Pharma A/S
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A